InvestorsHub Logo
Post# of 428
Next 10
Followers 0
Posts 12555
Boards Moderated 1
Alias Born 12/10/2004

Re: None

Saturday, 03/04/2006 12:28:43 AM

Saturday, March 04, 2006 12:28:43 AM

Post# of 428
XKEM --------Federal Government has approved the sum of $28 million as
counterpart commitment for the project.---------- Market CAP of XKEM 3
millions Very Undervalue ! Ready to Fly 0.010 cents !: XKEM ----
Last chance to BUY BUY BUY under 0.02 cents ----- BUY CONFIRMED

XKEM ----- 127 million Volume NEW RECORD -- UP 25% - BUY BUY BUY
ALERT ALERT Last time to BUY UNDER 0.02 cents ------Short TIME Prize
target Above 0.03 under 0.05 cents !

XKEM alert The SouthEnd Stock Pickers helps investors win at
investing on the merits of radically original thinking and an unbeatable track
record of picking stocks with huge potential. We're here for you with
commonsense, the big ideas, and a little inspiration to turn your
portfolio into a monster performer. We've brought you GTE, GOOG, SIRI, CMGI,
JDSU,HISC, and others you've made a killing on! If it doesn't make
commonsense, it makes nosense to us or you.
At SouthEnd Stock Pickers, we're focusing solely on undervalued
Nasdaq stocks that we feel will return potential profits of 500%+ in 1 to 3
weeks. Our New picks have hours and hours of research listed below.Our
SouthEnd Team uses a new breakthrough method of hardcore stock picks.$$
WE ARE HERE TO MAKE YOU MONEY $$
Our new pick for 22/FEB/2006 is =(XKEM) was picked up of (INSIDER
BUYING)
Accumulation........is the key word
Xechem International,Inc,
Ticker Symbol = XKEM
Market Cap = $ 1. 90M
Industry: Biotechnology
Target Price = $ 0.24
Recommendation: SUPER MEGA BUY
There are many reasons to buy into (XKEM) $DO YOUR DD A HUGE WINNER
HERE $
Once News on the Approval of the NIGERIA plant comes out SKY HIGH SHE
GOES .
Charts speak for them selfs
RSI strong buy
http://www.freewebs.com/stocktip/index.htm
http://stockcharts.com/h-sc/ui?s=xkem
Web Site: http://www.xechem.com
Xechem Closes On $4.2 Million Lawsuit Settlement With Bristol-Meyers
Squibb
Xechem International, Inc. (OTC BB: XKEM) Xechem International said
today that the $4.2 million settlement of its antitrust lawsuit against
Bristol-Meyers Squibb Co., announced December 2005, has closed and that
the net settlement proceeds have now been received by the company. (For
more information regarding the settlement, including the allocation of
proceeds, please refer to the Company's previously filed Form 8-K of
public record.) The lawsuit, filed against Bristol-Meyers in federal
district court in Chicago in 2003, centered on allegations that
Bristol-Meyers had engaged in anticompetitive practices relating to Xechem's
efforts to manufacture and bring to market the drug paclitaxel, a generic
equivalent of Bristol's cancer drug, TAXOL(R). Bristol-Meyers did not
admit to any wrongdoing as part of the settlement.
Settlement Proceeds To Be Used To Further Restructuring
Objectives and Xechem's Efforts to Launch Sickle Cell Drug
Dr. Ramesh C. Pandey, Xechem's chairman and CEO, said that the money
received by Xechem would be used, in part, to consummate Xechem's
previously announced restructuring with Alembic Limited and in part to move
Xechem closer to its goal of launching NICOSAN(TM)/HEMOXIN(TM), its
promising sickle cell drug: "In anticipation of this Bristol settlement, we
recently entered into a restructuring agreement with Alembic Ltd. which
calls for the release of Alembic's significant equity stake in our
Nigerian subsidiary and the cancellation of a significant 15-year gross
royalty from the future sales of our sickle cell drug in exchange for
accelerated debt repayment and certain collateral security. We intend to
use a portion of the settlement monies to meet our obligations under that
restructuring, with most of the rest of the money to be used to move us
closer to our goal of commercially launching the sickle cell drug."
Xechem has previously reported that it plans to bring NICOSAN(TM) to the
Nigerian market in early 2006, and at the same time, embark on the
clinical trials in the US hospitals for FDA approval through the
Investigational New Drug (IND) Application for sale of the drug in the United
States


charles wilson <profitablestock@yahoo.com> escribió:
UPDA closed .26 but in AH .288 run is inminent...news coming on
monday and oil price climbing fast


__________________________________________________
Do You Yahoo!?
Tired of spam? Yahoo! Mail has the best spam protection around
http://mail.yahoo.com

[Non-text portions of this message have been removed]


Live for Today - Learn for Tomorrow

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.